Docetaxel given after doxorubicin reduces recurrence

January 8, 2008

Adding the drug docetaxel to anthracycline-based chemotherapy slightly improved disease-free survival in breast cancer patients, according to a randomized clinical trial published online January 8 in the Journal of the National Cancer Institute.

Docetaxel has previously been shown to be more effective than doxorubicin (an anthracycline) for treating patients with advanced breast cancer. Therefore, researchers wanted to test it in patients receiving chemotherapy after surgery.

Prudence Francis, M.D., of the Peter MacCallum Cancer Centre in Melbourne, Australia, and colleagues conducted a randomized, controlled phase III trial that compared patients who received doxorubicin-based chemotherapy with and without docetaxel. The trial also examined whether docetaxel should be given after doxorubicin or at the same time. The researchers compared disease-free survival for each treatment.

Overall, patients receiving the docetaxel treatment had an improvement in disease-free survival that was borderline statistically significant. Patients receiving docetaxel after doxorubicin had a five-year disease-free survival rate of 78 percent, compared with 74 percent for those receiving the two drugs at the same time. Patients in the control arm—those who received only doxorubicin-based chemotherapy—had a five-year disease-free survival rate of 73 percent. However, there was no statistically significant difference in overall survival between patients who received docetaxel and those who did not.

“Important differences may be related to doxorubicin and docetaxel scheduling, with sequential, but not concurrent, administration appearing to produce better [disease-free survival] than anthracycline-based adjuvant chemotherapy,” the authors write.

Source: Journal of the National Cancer Institute


Rank not rated yet
Tags

Relevant PhysicsForums posts
  • Is Everyday Technology Killing Us?
    createdFeb 08, 2012
  • Exercise and weight loss
    createdFeb 08, 2012
  • Why do we have head aches? Our brains can't feel anything.
    createdFeb 07, 2012
  • "The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
    createdFeb 04, 2012
  • Oncolytic adenovirus
    createdFeb 04, 2012
  • Nutrition label stuffs and diets
    createdFeb 02, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Discovery paves way for salmonella vaccine

(Medical Xpress) -- An international research team led by a University of California, Davis, immunologist has taken an important step toward an effective vaccine against salmonella, a group of increasingly antibiotic-resistant ...

Medicine & Health / Research

created 12 minutes ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

First-of-its-kind stem cell study re-grows healthy heart muscle in heart attack patients

Results from a Cedars-Sinai Heart Institute clinical trial show that treating heart attack patients with an infusion of their own heart-derived cells helps damaged hearts re-grow healthy muscle.

Medicine & Health / Cardiology

created 18 minutes ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Ovarian cancer arises in fallopian tube of knockout mice

(Medical Xpress) -- The most deadly form of "ovarian" cancer arises in the fallopian tubes – not the ovaries – of knockout mice that lack two genes associated with the disease, said researchers led by Baylor College ...

Medicine & Health / Cancer

created 13 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Smoking bans lead to less, not more, smoking at home: study

Smoking bans in public/workplaces don't drive smokers to light up more at home, suggests a study of four European countries with smoke free legislation, published online in Tobacco Control.

Medicine & Health / Health

created 18 minutes ago | popularity not rated yet | comments 0

UK cases of progressive sight loss condition set to rise a third by 2020

New cases of the progressive sight loss condition, known as age-related macular degeneration, or AMD for short, are set to rise by a third in the UK over the next decade, reveals research published online in the British Jo ...

Medicine & Health / Diseases

created 17 minutes ago | popularity not rated yet | comments 0


Scientists discover reason for Mt. Hood's non-explosive nature

(PhysOrg.com) -- For a half-million years, Mount Hood has towered over the landscape, but unlike some of its cousins in Oregon’s Cascade Mountains and many other volcanoes around the Pacific “Rim ...

Time of year important in projections of climate change effects on ecosystems

(PhysOrg.com) -- Does it matter whether long periods of hot weather, such as last year's heat wave that gripped the U.S. Midwest, happen in June or July, August or September?

Medical school link to wide variations in pass rate for specialist exam

Wide variations in doctors' pass rates, for a professional exam that is essential for one type of specialty training, seem to be linked to the particular medical school where the student graduated, indicates research published ...

Missing dark matter located: Intergalactic space is filled with dark matter

Researchers at the University of Tokyo’s Institute for the Physics and Mathematics of the Universe (IPMU) and Nagoya University used large-scale computer simulations and recent observational data of gravitational ...

Plants use circadian rhythms to prepare for battle with insects

In a study of the molecular underpinnings of plants' pest resistance, Rice University biologists have shown that plants both anticipate daytime raids by hungry insects and make sophisticated preparations to ...

Sensing self and non-self: New research into immune tolerance

At the most basic level, the immune system must distinguish self from non-self, that is, it must discriminate between the molecular signatures of invading pathogens (non-self antigens) and cellular constituents that usually ...